Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry

New Anti-Malarial Technologies Approaching Maturation

June 2012 | Industry Trend Analysis

BMI View: Drugs that have been designed for the lucrative developed markets cannot be produced cheaply enough for African healthcare needs, but research and development (R&D) funded by donations allows for the design of drugs, vaccines, vector control methods and diagnostic products that can help to solve Africa's problems. These inventions also increase Africa's productive population, which is a boon for economic growth, which then feeds back into consumption.

To read the full article, please choose one of the following options:

Subcribers please log in

Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries